Valuation: Tiansheng Pharmaceutical Group Co., Ltd.

Market Cap 142.15Cr 21Cr 18Cr 17Cr 16Cr 30Cr 1.98TCr 30Cr 203.4Cr 79Cr 975.28Cr 79Cr 77Cr 3.39TCr P/E 2024
-16.5x
P/E 2025 -27.9x
Enterprise Value 150.04Cr 22Cr 19Cr 18Cr 17Cr 31Cr 2.09TCr 32Cr 214.69Cr 83Cr 1.03TCr 83Cr 81Cr 3.57TCr EV / Sales 2024
2.7x
EV / Sales 2025 3.16x
Free-Float
51.3%
Yield 2024 *
-
Yield 2025 -
08/05 Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement MT
28/04 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
28/04 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
12/02 Three Tiansheng Pharma Drugs Set to Win Bids for China's Drug Procurement Program MT
07/11 Tiansheng pharmaceutical and its controlling shareholder penalised, fined RE
29/25/29 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
14/25/14 Tiansheng Pharmaceutical Group Subsidiaries Tentatively Win Bulk Drug Tenders in Guangdong MT
15/25/15 Tiansheng Pharmaceutical Gets China Supplementary Drug Approval for Sodium Bicarbonate Injection MT
27/25/27 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
28/25/28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
28/25/28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
10/25/10 Tiansheng Pharmaceutical Passes Consistency Evaluation for Antibiotic MT
26/24/26 Chongqing Pharmaceutical Group Changsheng Pharmaceutical Co., Ltd announced that it expects to receive CNY 60 million in funding from C.Q. Pharmaceutical Holding Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd. CI
1 day-1.11%
1 week-7.45%
Current month-17.22%
1 month-17.22%
3 months-13.87%
6 months-8.02%
Current year-8.02%
1 week 4.32
Extreme 4.32
4.92
1 month 4.32
Extreme 4.32
5.56
Current year 4.32
Extreme 4.32
5.65
1 year 4.32
Extreme 4.32
5.81
3 years 3.17
Extreme 3.17
5.97
5 years 3.17
Extreme 3.17
5.99
10 years 3.17
Extreme 3.17
35.18
Manager TitleAgeSince
Chief Executive Officer 33 06/12/2018
Director of Finance/CFO 52 23/12/2013
Corporate Officer/Principal 54 11/12/2020
Director TitleAgeSince
Director/Board Member 63 11/12/2020
Chairman 33 06/12/2018
Director/Board Member 54 11/12/2020
Date Insider Type Main position Quantity % Market Cap.
25/23/25Sell

Chief Financial Officer

43,100 0.0205%
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%-7.45%-4.49%-12.52% 21Cr
+1.81%+11.60%+58.61%+164.79% 1,09700Cr
+1.51%+11.77%+69.61%+57.53% 62TCr
+0.38%+10.56%+39.49%+90.88% 45TCr
-0.37%+6.34%+29.51%+24.01% 33TCr
+1.41%+6.46%+42.96%+28.31% 29TCr
+1.28%+3.42%+32.72%+41.82% 29TCr
+1.27%+3.67%-27.42%-41.96% 21TCr
+0.62%+4.59%+30.10%+63.03% 19TCr
-1.21%+1.17%+14.15%+66.20% 16TCr
Average +0.04%+5.25%+28.53%+48.21% 36.47TCr
Weighted average by Cap. +0.01%+8.72%+43.71%+82.09%

Financials

2024 2025
Net sales 57Cr 8.38Cr 7.34Cr 6.77Cr 6.33Cr 12Cr 792.34Cr 12Cr 82Cr 31Cr 390.89Cr 31Cr 31Cr 1.36TCr 51Cr 7.56Cr 6.62Cr 6.11Cr 5.71Cr 11Cr 714.98Cr 11Cr 74Cr 28Cr 352.72Cr 28Cr 28Cr 1.22TCr
Net income -8.74Cr -1.29Cr -1.13Cr -1.04Cr -97.05L -1.83Cr -121.56Cr -1.87Cr -13Cr -4.83Cr -60Cr -4.83Cr -4.72Cr -208.21Cr -5.54Cr -81.53L -71.39L -65.9L -61.54L -1.16Cr -77Cr -1.18Cr -7.93Cr -3.06Cr -38Cr -3.06Cr -2.99Cr -132.03Cr
Net Debt 9.72Cr 1.43Cr 1.25Cr 1.16Cr 1.08Cr 2.03Cr 135.17Cr 2.08Cr 14Cr 5.37Cr 67Cr 5.37Cr 5.25Cr 231.51Cr 7.89Cr 1.16Cr 1.02Cr 93.85L 87.64L 1.65Cr 109.77Cr 1.69Cr 11Cr 4.36Cr 54Cr 4.36Cr 4.26Cr 188.02Cr
Logo Tiansheng Pharmaceutical Group Co., Ltd.
Tiansheng Pharmaceutical Group Co Ltd is a China-based company primarily engaged in drug R&D, production, sales, and the cultivation and processing of traditional Chinese medicinal materials. The Company's products include tablets, capsules, granules, teas, pills, and injections. Product varieties cover pediatrics, gynecology, cardiovascular system, digestive system, orthopedics, respiratory medicine, and anti-infective treatment areas. The Company's products are mainly sold to the domestic market.
Employees
1,273
Date Price Change Volume
29/26/29 CN¥4.470 -1.11% 34,47,700
26/26/26 CN¥4.520 -2.59% 23,67,850
25/26/25 CN¥4.640 -2.32% 31,90,850
24/26/24 CN¥4.750 -2.86% 31,56,500
23/26/23 CN¥4.890 +1.24% 40,40,000
  1. Stock Market
  2. Stocks
  3. 002872 Stock